These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 5654209

  • 1. Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride.
    Baker BR, Hurlbut JA.
    J Med Chem; 1968 Mar; 11(2):241-5. PubMed ID: 5654209
    [No Abstract] [Full Text] [Related]

  • 2. Irreversible enzyme inhibitors. 113. Proteolytic enzymes. 3. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides with an N-fluorosulfonylphenyl substituent.
    Baker BR, Hurlbut JA.
    J Med Chem; 1968 Mar; 11(2):233-41. PubMed ID: 5654208
    [No Abstract] [Full Text] [Related]

  • 3. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
    Baker BR, Hurlbut JA.
    J Med Chem; 1969 Jan; 12(1):118-22. PubMed ID: 5763006
    [No Abstract] [Full Text] [Related]

  • 4. Irreversible enzyme inhibitors. CXV. Proteolytic enzymes. V. Active-site-directed irreversible inhibitors of trypsin derived from p-(phenoxyalkoxy) benzamidines with a terminal sulfonyl fluoride.
    Baker BR, Erickson EH.
    J Med Chem; 1968 Mar; 11(2):245-9. PubMed ID: 5654210
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Irreversible enzyme inhibitors. CXLIV. Proteolytic enzymes. VII. Additonal active-site-directed irreversible inhibitors of trypsin derived from m- and p-(phenoxyalkoxy)benzamidines with a terminal sulfonyl fluoride.
    Baker BR, Erickson EH.
    J Med Chem; 1969 Jan; 12(1):112-7. PubMed ID: 5763005
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR, Meyer RB.
    J Med Chem; 1969 Jan; 12(1):104-7. PubMed ID: 5763003
    [No Abstract] [Full Text] [Related]

  • 11. Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride.
    Baker BR, Meyer RB.
    J Med Chem; 1969 Jan; 12(1):108-11. PubMed ID: 5763004
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Irreversible enzyme inhibitors. CXL. Active-site-directed irreversible inhibitors derived from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
    Baker BR, Lourens GJ.
    J Med Chem; 1969 Jan; 12(1):95-101. PubMed ID: 5763050
    [No Abstract] [Full Text] [Related]

  • 14. Irreversible enzyme inhibitors. CL. Proteolytic enzymes. IX. (3,4-Dichlorophenoxyacetamido)pyridines bridged by a quaternary salt to a terminal sulfonyl fluoride. Potent irreversible inhibitors of alpha-chymotrypsin.
    Baker BR, Hurlbut JA.
    J Med Chem; 1969 Mar; 12(2):221-4. PubMed ID: 5783594
    [No Abstract] [Full Text] [Related]

  • 15. Irreversible enzyme inhibitors. CXLVII. Candidate active-site-directed irreversible inhibitors of xanthine oxidase derived from 9-(p-acylamidoalkoxyphenyl)guanines bearing a terminal sulfonyl fluoride.
    Baker BR, Wood WF.
    J Med Chem; 1969 Mar; 12(2):214-6. PubMed ID: 5783592
    [No Abstract] [Full Text] [Related]

  • 16. Irreversible enzyme inhibitors. 183. Proteolytic enzymes. 18. Inhibitors of guinea pig complement derived by quaternization of phenylalkylpyridines with -bromomethylbenzenesulfonyl fluorides.
    Baker BR, Doll MH.
    J Med Chem; 1971 Sep; 14(9):793-9. PubMed ID: 5168671
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 2-phenylethaneboronic acid, a possible transition-state analog for chymotrypsin.
    Koehler KA, Lienhard GE.
    Biochemistry; 1971 Jun 22; 10(13):2477-83. PubMed ID: 5557796
    [No Abstract] [Full Text] [Related]

  • 20. Irreversible enzyme inhibitors. 148. Active-site-directed irreversible inhibitors of guanine deaminase derived from 9-phenylguanine bearing a terminal sulfonyl fluoride.
    Baker BR, Wood WF.
    J Med Chem; 1969 Mar 22; 12(2):216-20. PubMed ID: 5783593
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.